First Trust NYSE Arca Biotechnology Index Fund (FBT)

Assets	$2.94B
Expense Ratio	0.55%
PE Ratio	27.39
Shares Out	10.85M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	6,139
Open	270.25
Previous Close	268.96
Day's Range	270.25 - 272.32
52-Week Low	171.00
52-Week High	275.29
Beta	0.66
Holdings	32
Inception Date	Jun 19, 2006

About FBT

Fund Home Page

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is issued by First Trust.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: FBT
• ETF Provider: First Trust
• Index Tracked: NYSE Arca Biotechnology Index

Top 10 Holdings

38.22% of assets

Name	Symbol	Weight
Halozyme Therapeutics, Inc.	HALO	4.28%
Regeneron Pharmaceuticals, Inc.	REGN	3.93%
Corcept Therapeutics Incorporated	CORT	3.90%
BeOne Medicines AG	ONC	3.86%
NeoGenomics, Inc.	NEO	3.77%
Repligen Corporation	RGEN	3.76%
BioMarin Pharmaceutical Inc.	BMRN	3.76%
Natera, Inc.	NTRA	3.73%
Amgen Inc.	AMGN	3.73%
Genmab A/S	GMAB	3.50%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 13, 2024	$1.1726	Dec 31, 2024
Sep 23, 2015	$0.0197	Sep 30, 2015
Jun 24, 2015	$0.0649	Jun 30, 2015
Mar 25, 2015	$0.0476	Mar 31, 2015
Dec 23, 2014	$0.0524	Dec 31, 2014
Jun 23, 2008	$0.2697	Jun 30, 2008

Performance

FBT had a total return of 57.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.99%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Aug 25, 2026

Data Sources Report a data error